Tufan I. Türkiye'nin yaşlılık yükü gerçekten hafif midir? Birinci Türkiye Yaşlılık Raporu. Antalya, Gero Yay, 2007.
Yaman H. Yaşlılarda sporun fizyolojik fonksiyon kaybına etkisi. Geriatri 2003; 6: 142-6.
Active Ageing-A Policy Framework. Geneva: WHO. 2002. http://whqlib-doc.who.int/hq/2002/WHO_NMH_NPH_02.8.pdf. Erişim tarihi:
15.08.2008.
Sandholzer H, Keyser M, Fischer GC. Ambulantes geriatrisches Assessment in der allgemeinarztlichen Sprechstunde- Wie hâufig werden therapeutische Konsequenzen gezogen? Notfall & Hausarztmedizin 2007;
33: 20-3.
Yaman H, Akdeniz M, Kanevetçi Z. Ülkemizde beklenilen demografik değişime hazırlık: Yaşlı dostu birincil bakım merkezleri. RNA Aile Hekimliği Dergisi 2008; 2: 14-21.
Dünya Sağlık Örgütü. Yaşlı Dostu Birincil Bakım Merkezleri Enstrümanı. 2008. http://www.ailehek.org. Erişim tarihi 12.11.2008. van Schayck OC, Pinnock H, Ostrem A ve ark. IPCRG Consensus state¬ment: tackling the smoking epidemic - practical guidance for primary care. Prim Care Respir J. 2008; 17: 185-93.
Spalding MC, Sebesta SC. Geriatric screening and preventive care. Am Fam Physician 2008; 78: 206-15.
Mozaffarian D, Katan
MB
, Ascherio A, Stampfer MJ, Willett WC. Trans fatty acids and cardiovascular disease. N Engl J Med2006; 354: 1601-13. Knoops KT, de Groot LC, Kromhout D ve ark. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and
women: the HALE project. JAMA2004; 292: 1433-9.
Sandholzer H, Hellenbrand W, Ranteln-Kruse W ve ark. STEP-Standardized assessment for elderly people in primary care- Europâische Leitlinie für das standardisierte evidenzbasierte praventative Assessment âlterer Menschen in der medizinischen Primarversorgung. Dtsch Med
Wochenschr2004; 129: 183-226.
U.S. Department of Health and Human Services, Public Health Service. Aspirin for the Primary Prevention of Cardiovascular Events, January 2002.. http://www.ahrq.gov/clinic/uspstf/uspsasmi.htm. Accessed July 28,
2008.
Walter LC, Covinsky KE. Cancer screening in elderly patients: a frame¬work for individualized decision making. JAMA 2001; 285: 2750-6. Flaherty JH, Morley JE, Murphy DJ, Wasserman MR. The development of outpatient clinical glidepaths. J Am Geriatr Soc 2002; 50: 1886-1901. Reidy A, Minassian DC, Vafidis G ve ark. Prevalence of serious eye dis¬ease and visual impairment in a north London population: population based, cross sectional study. BMJ 1998; 316: 1643-6. Debbie A, Lawlor RP, Ebrahim S. Association between falls in elderly women and chronic diseases and drug use: cross sectional study. BMJ
2003; 327: 712-7.
Smeeth L, Iliffe S. Community screening for visual impairment in the
elderly. Cochrane Database Syst Rev 2006; 19: 3. CD001054.
US Department of Health and Human Services, Public Health Service. Screening for Hearing Impairment in Older Adults. 1996. http://www.ncbi.nlm.nih.gov/ books/bv.fcgi?rid=hstat3.section.10931#13811. Erişim tarihi: 28.07.2008.
Pirozzo S, Papinczak T, Glasziou P. Whispered voice test for screening for hearing impairment in adults and children: systematic review. BMJ
2003; 327: 967.
Mulrow C, Lau J, Cornell J, Brand M. Pharmacotherapy for hypertension
in the elderly. Cochrane Database Syst Rev 1998, 2: CD000028. DOI: 10.1002/14651858.
21. Nigel S Beckett, Ruth Peters, Astrid E Fletcher ve ark. Treatment of hypertension in patients 80 years of age or older. N Engl J Med2008; 358:
1887-98.
22. Murphy NF, Simpson CR, Jhund PS ve ark. A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibril¬lation in Scotland. Heart 2007; 93: 606-12.
23. Heeringa J, van der Kuip DAM, Hofman A ve ark. Prevalence, incidence
and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J
2006; 27: 949-53.
24. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 1991; 22: 983-8.
25. Hellemons BSP, Langenberg M, Lodder J ve ark. Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin. BMJ 1999; 319: 175-8.
26. Mant J, Hobbs FD, Fletcher K ve ark. BAFTA investigators; Midland Research Practices Network (MidReC). Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrilla¬tion (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007; 370: 493-503.
27. Stroke prevention in atrial fibrillation study: final results. Circulation
1991; 84: 527-39.
28. Fitzmaurice DA, Hobbs FD, Jowett S ve ark. Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: clus¬ter randomised controlled trial. BMJ2007; 335: 355-6.
29. Domanski MJ, Exner DV, Borkowf CB, Geller NL, Rosenberg Y, Pfeffer MA. Effect of angiotensin converting enzyme inhibition on sudden car¬diac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials. J Am Coll Cardiol 1999; 33: 598-604.
30. Yusuf S, Sleight P, Pogue J, Davies R, Dasenais G. The Heart Outcomes Prevention EvalutionStudy Investigators. Effects of an angiotensin- con¬verting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk
patients. N Engl J Med2000; 342: 145-53.
31. Cucherat M. Quantitative relationship between resting heart rate reduc¬tion and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials. Eur Heart J2007; 28: 3012¬9.
32. Campbell NC, Thain J, Deans HG, Ritchie LD, Rawles JM. Secondary prevention in coronary heart disease: baseline survey of provision in gen¬eral practice. BMJ 1998; 316: 1400-1.
33. Dewhurst G, Wood DA, Walker F ve ark. A population survey of cardio¬vascular disease in elderly people: design, methods and prevalence results.
Age Ageing1991; 20: 353-60.
34. Hanna IR, Wenger NK. Secondary prevention of coronary heart disease in elderly patients. Am Fam Physician 2005; 71: 2289-96.
35. Guidelines on the management of stable angina pectoris: executive sum¬mary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J2006; 27: 1341-81.
36. Duprez DA. Pharmacological interventions for peripheral artery disease. Expert Opin Pharmacother 2007; 8: 1465-77.
37. Leng GC, Price JF, Jepson RG. Lipid-lowering for lower limb athero¬sclerosis. Cochrane Database Syst Rev 2000; 2: CD000123.
38. Leng GC, Fowler B, Ernst E. Exercise for intermittent claudication. Cochrane Database Syst Rev 2000; 2: CD000990.
39. Aronow WS. Treatment of high-risk older persons with lipid-lowering drug therapy. Am J Ther 2008; 15: 102-7.
40. ATP III Update 2004: Implications of Recent Clinical Trials for the ATP III
Guidelines. http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3upd04.htm Erişim tarihi: 10.08.2008.
1.
2.
3.
4.
5.
6.
o
e 3
7.
8.
9.
Türkiye Aile Hekimliği Dergisi
I
Turkish Journal of Family Practice I Cilt 13 | Sayı 1 I 2009
37
41. Henyan NN, Riche DM, East HE, Gann PN. Impact of statins on risk of stroke: a meta-analysis. Ann Pharmacother 2007; 41: 2055-7. Horsley JR, Sterling IJ, Waters WE, Howel JB. Respiratory symptoms among elderly people in the New Forest area as assessed by postal ques¬tionnaire. Age Ageing1991; 20: 325-31.
U.S. Preventive Services Task Force. Screening for type 2 diabetes melli-tus in adults: U.S. Preventive Services Task Force recommendation state¬ment. Ann Intern Med 2008; 148: 846-54.
Croxson SC, Burden AC, Bodington M, Botha JL.The prevalence of dia¬betes in elderly people. Diabet Med1991; 8: 2831.
Sandbaek A, Griffin SJ, Rutten G ve ark. Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study. Diabetologia 2008; 51: 1127-34. American Diabetes Association. Standards of medical care in diabetes-¬2008. Diabetes Care 2008; 31: 12-54.
Wilson GR, Curry RW Jr. Subclinical thyroid disease. Am Fam Physician
2005; 72: 1517-24.
Brochmann H, Bjoro T, Gaorder P ve ark. Prevalence of thyroid dys¬function in elderly subjects. Acta Endocrin 1998; 117: 7-12. Knudsen N, Jorgensen T, Rasmussen S ve ark. The prevalence of thyroid dysfunction in a population with borderline iodine deficiency. Clin
Endocrinol1999; 51: 361-7.
Anderson CS, Jamrozik KD, Burvil PW, Chakera TM, Johnson GA, Stewart Wynne EG. Ascertaining the true incidence of stroke:experience
from the Perth Community Stroke Study.1989-1990. Med J Aust 1993; 158: 80-4.
Hofman A, Rocca WA, Brayne C ve ark. The prevalence of dementia in Europe:a collaborative study of 1980-1990 findings. Eurodem Prevalence Research Group. Int J Epidemiol 1991; 20: 736-48.
52. Lobo A, Lavner LJ, Fratiglioni L ve ark. Prevalence of dementia and major subtypes in Europe:A collaborative study of population-based cohorts. Neurology2000; 54: 4-9.
53. Gurvit H, Emre M, Tinaz S ve ark. The prevalence of dementia in an urban Turkish population. Am J Alzheimers Dis Other Demen 2008; 23:
67-76.
Keskinoglu P, Giray H, Picakciefe M, Bilgic N, Ucku R. The prevalence and risk factors of dementia in the elderly population in a low socio-eco¬nomic region of Izmir, Turkey. Arch Gerontol Geriatr 2006; 43: 93-100. Koenig HG, Blazer DG. Epidemiology geriatric affective disorders. Clin
Geriatr Med1992; 8: 235-51.
Kessler D, Lloyd K, Lewis G, Gray DP. Cross sectional study of symp¬tom attribution and recognition of depression and anxiety in primary
care. BMJ1999; 318: 436-9.
57. Davies R, Bedi R, Scully C. ABC of oral health: Oral health care for
patients with special needs. BMJ2000; 321: 495-8.
Romero Y, Evans JM, Fleming KC, Phillips SF. Constipation and faecal incontinence in the elderly population. Mayo Clin Proc 1996; 71: 81-92.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
54.
55.
56.
58.
59. Thom D. Variation in estimates of urinary incontinence prevalence in the community: effects of differences in defintion, population characteristics
and study type. JAG 1998; 46: 473-80.
60. Wagg A, Cohen M. Medical therapy for the overactive bladder in the eld¬erly. Age Ageing2002; 31: 241-6.
61. Nabi G, Cody JD, Ellis G, Herbison P, Hay-Smith J. Anticholinergic drugs versus placebo for overactive bladder syndrome in adults. Cochrane
Database Syst Rev 2006; 18: CD003781.
62. U.S. Department of Health and Human Services, Public Health Service. Screening for Prostate Cancer. August, 2008. http://www.ahrq.gov/clin- ic/uspstf08/prostate/prostatesum.pdf. Erişim tarihi: 12.08.2008.
63. Kanis JA, Burlet N, Cooper C ve ark. European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2008; 19: 399-428.
64. Qaseem A, Snow V, Shekelle P, Hopkins R Jr, Forciea MA, Owens DK. Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Screening for osteoporosis in men: a clinical practice guide¬line from the American College of Physicians. Ann Intern Med 2008; 148:
680-4.
65. O'Neill S, MacLennan A, Bass S ve ark. Osteoporosis Australia Medical Scientific Committee. Guidelines for the management of postmenopausal osteoporosis for GPs. Aust Fam Physician 2004; 33: 910-9.
66. Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A. Use of calci¬um or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analy-
sis. Lancet 2007; 370: 657-66.
67. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Effects of statins on bone mineral density: a meta-analysis of clinical studies. Bone 2007; 40:
1581-7.
68. Woolf AD, Akesson K. Preventing fractures in elderly people. BMJ 2003;
327: 89-95.
69. Sawka AM, Boulos P, Beattie K, ve ark. Hip protectors decrease hip frac¬ture risk in elderly nursing home residents: a Bayesian meta-analysis. J
Clin Epidemiol2007; 60: 336-44.
70. Parker MJ, Gillespie WJ, Gillespie LD. Effectiveness of hip protectors for preventing hip fractures in elderly people: systematic review. BMJ
2006; 332: 571-4.
71. Managing Osteoarthritis: Helping the Elderly Maintain Function and Mobility. AHRQ-REsearch in Action. 2002. vol 4. http://ahrq.hhs.gov/ research/osteoria/osteoria.pdf. Erişim tarihi: 11.08.2008.
72. Kerse NM, Flicker L, Jolley D, Arroll B, Young D. Improving the health behaviours of elderly people: randomised controlled trial of a general practice education programme. BMJ1999; 319: 683-7.
73. Beswick AD, Rees K, Dieppe P ve ark. Complex interventions to improve physical function and maintain independent living in elderly people: a sys¬tematic review and meta-analysis. Lancet 2008; 371: 725-35.
74. McGarry J, Arthur A. Can over-75 health checks identify unmet need? Nursing Standart1999; 13: 37-9.
Thank you for copying data from http://www.arastirmax.com
